IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATHLEEN P PEARL

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health

NPI
1851392344
CMS profile
10791888
Location
BOSTON, MA

General Payments · PY2021–2024

$4,811.81

  • Reported across 283 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$846.10

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Adult Health MA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $846.10 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $147.61 12
Mirati Therapeutics, Inc. $93.02 5
Acerta Pharma LLC $92.22 5
Daiichi Sankyo Inc. $85.80 5
PFIZER INC. $85.48 5
Merck Sharp & Dohme Corporation $70.28 4
GlaxoSmithKline, LLC. $51.44 3
Lilly USA, LLC $36.89 2
E.R. Squibb & Sons, L.L.C. $34.01 2
TAIHO ONCOLOGY, INC. $31.75 2
Celgene Corporation $19.31 1
EISAI INC. $17.18 1
RECORDATI_RARE_DISEASES_INC. $16.82 1
Alexion Pharmaceuticals, Inc. $16.81 1
Janssen Biotech, Inc. $16.72 1
Galvanize Therapeutics, Inc $15.76 1
Genentech USA, Inc. $15.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $942.06 44
PY2022 $1,324.29 80
PY2023 $1,699.36 107
PY2024 $846.10 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $16.81 02/01/2024 Food and Beverage Undisputed 01/23/2026 1093926412 CMS
AstraZeneca Pharmaceuticals LP $18.44 01/25/2024 Food and Beverage Undisputed 01/23/2026 1104710987 CMS
AstraZeneca Pharmaceuticals LP $18.46 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104247123 CMS
AstraZeneca Pharmaceuticals LP $18.42 03/29/2024 Food and Beverage Undisputed 01/23/2026 1105704678 CMS
AstraZeneca Pharmaceuticals LP $18.42 04/30/2024 Food and Beverage Undisputed 01/23/2026 1104384219 CMS
AstraZeneca Pharmaceuticals LP $18.48 07/11/2024 Food and Beverage Undisputed 01/23/2026 1104607924 CMS
Celgene Corporation $19.31 07/15/2024 Food and Beverage Undisputed 01/23/2026 1101120919 CMS
Daiichi Sankyo Inc. $17.00 01/10/2024 Food and Beverage Undisputed 01/23/2026 1089468256 CMS
Daiichi Sankyo Inc. $17.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 1089468260 CMS
Daiichi Sankyo Inc. $16.81 02/23/2024 Food and Beverage Undisputed 01/23/2026 1089468258 CMS
Daiichi Sankyo Inc. $16.45 05/31/2024 Food and Beverage Undisputed 01/23/2026 1089468262 CMS
Daiichi Sankyo Inc. $18.54 07/15/2024 Food and Beverage Undisputed 01/23/2026 1089468264 CMS
E.R. Squibb & Sons, L.L.C. $16.11 01/16/2024 Food and Beverage Undisputed 01/23/2026 1101370724 CMS
E.R. Squibb & Sons, L.L.C. $17.90 07/23/2024 Food and Beverage Undisputed 01/23/2026 1101370782 CMS
Eisai Inc. $17.18 02/20/2024 Food and Beverage Undisputed 01/23/2026 1110808210 CMS
Galvanize Therapeutics, Inc $15.76 08/20/2024 Food and Beverage Undisputed 01/23/2026 1144505288 CMS
Genentech USA, Inc. $15.00 06/12/2024 Food and Beverage Undisputed 01/23/2026 1133167065 CMS
GlaxoSmithKline, LLC. $14.86 01/19/2024 Food and Beverage Undisputed 01/23/2026 1116523240 CMS
GlaxoSmithKline, LLC. $17.81 04/23/2024 Food and Beverage Undisputed 01/23/2026 1116624389 CMS
GlaxoSmithKline, LLC. $18.77 06/07/2024 Food and Beverage Undisputed 01/23/2026 1115917561 CMS
Janssen Biotech, Inc. $16.72 01/04/2024 Food and Beverage Undisputed 01/23/2026 1078361785 CMS
Lilly USA, LLC $18.44 02/21/2024 Food and Beverage Undisputed 01/23/2026 1135714318 CMS
Lilly USA, LLC $18.45 03/20/2024 Food and Beverage Undisputed 01/23/2026 1135734901 CMS
Merck Sharp & Dohme LLC $14.88 01/11/2024 Food and Beverage Undisputed 01/23/2026 1141891510 CMS
Merck Sharp & Dohme LLC $18.88 02/15/2024 Food and Beverage Undisputed 01/23/2026 1141757756 CMS
Merck Sharp & Dohme LLC $18.50 05/06/2024 Food and Beverage Undisputed 01/23/2026 1141757612 CMS
Merck Sharp & Dohme LLC $18.02 05/23/2024 Food and Beverage Undisputed 01/23/2026 1141757742 CMS
Mirati Therapeutics, Inc. $18.90 02/06/2024 Food and Beverage Undisputed 01/23/2026 1117166621 CMS
Mirati Therapeutics, Inc. $19.55 04/08/2024 Food and Beverage Undisputed 01/23/2026 1117166625 CMS
Mirati Therapeutics, Inc. $16.57 05/10/2024 Food and Beverage Undisputed 01/23/2026 1117166629 CMS
Mirati Therapeutics, Inc. $19.00 07/09/2024 Food and Beverage Undisputed 01/23/2026 1117166613 CMS
Mirati Therapeutics, Inc. $19.00 10/31/2024 Food and Beverage Undisputed 01/23/2026 1117166617 CMS
Novartis Pharmaceuticals Corporation $14.84 01/08/2024 Food and Beverage Undisputed 01/23/2026 1087212273 CMS
Novartis Pharmaceuticals Corporation $11.55 01/26/2024 Food and Beverage Undisputed 01/23/2026 1087212283 CMS
Novartis Pharmaceuticals Corporation $15.31 02/07/2024 Food and Beverage Undisputed 01/23/2026 1087212281 CMS
Novartis Pharmaceuticals Corporation $10.03 02/08/2024 Food and Beverage Undisputed 01/23/2026 1087212275 CMS
Novartis Pharmaceuticals Corporation $14.75 02/12/2024 Food and Beverage Undisputed 01/23/2026 1087212279 CMS
Novartis Pharmaceuticals Corporation $8.48 03/22/2024 Food and Beverage Undisputed 01/23/2026 1087212291 CMS
Novartis Pharmaceuticals Corporation $14.66 04/09/2024 Food and Beverage Undisputed 01/23/2026 1087212289 CMS
Novartis Pharmaceuticals Corporation $9.19 04/23/2024 Food and Beverage Undisputed 01/23/2026 1087212299 CMS
Novartis Pharmaceuticals Corporation $12.33 05/22/2024 Food and Beverage Undisputed 01/23/2026 1087212303 CMS
Novartis Pharmaceuticals Corporation $10.70 07/23/2024 Food and Beverage Undisputed 01/23/2026 1087212317 CMS
Novartis Pharmaceuticals Corporation $9.80 08/12/2024 Food and Beverage Undisputed 01/23/2026 1087212321 CMS
Novartis Pharmaceuticals Corporation $15.97 11/18/2024 Food and Beverage Undisputed 01/23/2026 1087212333 CMS
PFIZER INC. $17.00 01/17/2024 Food and Beverage Undisputed 01/23/2026 1131283938 CMS
PFIZER INC. $17.00 04/25/2024 Food and Beverage Undisputed 01/23/2026 1131305801 CMS
PFIZER INC. $17.00 05/20/2024 Food and Beverage Undisputed 01/23/2026 1131305878 CMS
PFIZER INC. $17.00 07/17/2024 Food and Beverage Undisputed 01/23/2026 1131337251 CMS
PFIZER INC. $17.48 09/20/2024 Food and Beverage Undisputed 01/23/2026 1131361992 CMS
RECORDATI_RARE_DISEASES_INC. $16.82 05/07/2024 Food and Beverage Undisputed 01/23/2026 1139170261 CMS
TAIHO ONCOLOGY, INC. $16.45 01/09/2024 Food and Beverage Undisputed 01/23/2026 1137942366 CMS
TAIHO ONCOLOGY, INC. $15.30 03/29/2024 Food and Beverage Undisputed 01/23/2026 1137938734 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.